Immunovant, Inc. IMVT R&D credit carryforward
Discontinued — last reported Q4 '20
R&D credit carryforward at other companies
Segments
By geography
See fullOther financials
Where this comes from
Reported directly by Immunovant, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch.
The official record: Immunovant, Inc.’s 10-K, filed June 29, 2020, on SEC EDGAR. View the filing →